Buy, sell, hold: 6 stocks to watch out for your portfolio

Adani PortsCredit Suisse has maintained outperform rating on the stock with a target price of Rs 360 as it feels valuations are reasonable at 16X FY19 estimated earnings.Dhamra Port is a key beneficiary of potential scale-up of iron ore exports and the company has potential to generate strong operating cash flow of Rs 6,000 crore per year, it says.Credit Suisse feels iron ore price correction, export duties and mining regulation are key risks.Jindal Steel & PowerCredit Suisse has retained its outperform call on the stock, saying production may more than triple to 3.6 million tonne per annum by FY18-end.The company expects its Angul's EBITDA to triple from current levels. Hence, Angul EBITDA calculations could add 30 percent to consolidated FY17 EBITDA, the brokerage house says.Citi has reiterated its buy call on JSPL, with increased target price at Rs 200 from Rs 140. The stock is trading significantly below book value, it feels.The brokerage house says operational capacity has potential to generate significantly higher EBITDA.Citi believes court verdict on Gare Palma/ Tara Block does not impact fundamentals. Volume ramp-up is the key hereon, it says.Morgan Stanley has equal-weight call on the stock, with a target price of Rs 68 as it feels delivering on ramp-up of the steel volumes is a key to earnings.Aurobindo PharmaAurobindo Pharma, the seventh largest generics manufacturer in the US by volume, is transforming from a simple generics player to one with a portfolio of more complex generics, Goldman Sachs says.The brokerage house forecasts 19 percent EBITDA growth over next 2 years versus peers' 12 percent, driven by new product launches in the US gaining momentum and leading to 14 percent topline growth; and 100bp margin expansion from an improving product mix towards complex generics.Despite current market focus on potential US policy changes, Goldman thinks its significant Enterprise Value/EBITDA discount at 30 percent to peers is unwarranted (though closer to US generics players) and will narrow over time.It says 12-month target price of Rs 934 offers 40 percent upside potential.ConsumerCLSA says HUL's personal care growth will exceed soaps & detergents. From FY07-16, the gap between personal care & soaps & detergents is merely 0.7 percent.Interestingly, hair oil segment saw 15 percent CAGR, comparable to most personal care products, the brokerage house says.It feels ITC's cigarettes division will gain share in the overall tobacco pie. Despite initial regulation, ITC is expected to gain market share from bidis.CLSA says Nestle India will outperform many of its peers. Its stock has returned a 21 percent CAGR in last 10 years against 25-30 percent from peers.